Literature DB >> 28237253

Comparison of intra-articular injection of plasma rich in growth factors versus hyaluronic acid following arthroscopy in the treatment of temporomandibular dysfunction: A randomised prospective study.

Martín Fernández-Ferro1, Jacinto Fernández-Sanromán2, Andrés Blanco-Carrión3, Alberto Costas-López2, Annahys López-Betancourt2, Jorge Arenaz-Bua2, Bogdan Stavaru Marinescu2.   

Abstract

PURPOSE: The main objective of our study was to evaluate the effectiveness of the injection of plasma rich in platelet-derived growth factors (PRGF) versus hyaluronic acid (HA) following arthroscopic surgery in patients diagnosed with internal derangement of the temporomandibular joint (TMJ) with osteoarthritis (OA).
MATERIALS AND METHODS: A total of 100 patients were randomised into two study groups. Group A (n = 50) received an injection of PRGF, and Group B (n = 50) received an injection of HA. The mean age was 35.5 years (range 18-77 years), and 88% of the patients were women. The pain intensity (visual analogue scale) and the extent of maximum mouth opening before and after the procedure were statistically analysed.
RESULTS: Better results were observed in the group treated with PRGF, with a significant reduction in pain at 18 months, compared with HA treatment. Regarding mouth opening, an increase was observed in both groups, with no significant difference.
CONCLUSIONS: The injection of PRGF following arthroscopy is more effective than the injection of HA with respect to pain in patients with advanced internal derangement of the TMJ.
Copyright © 2017 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Arthroscopy; Hyaluronic acid; Internal derangement; Osteoarthritis; Plasma rich in platelet-derived growth factors; Temporomandibular disorder

Mesh:

Substances:

Year:  2017        PMID: 28237253     DOI: 10.1016/j.jcms.2017.01.010

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  5 in total

Review 1.  Treatment of Mandibular Hypomobility by Injections into the Temporomandibular Joints: A Systematic Review of the Substances Used.

Authors:  Maciej Chęciński; Kamila Chęcińska; Zuzanna Nowak; Maciej Sikora; Dariusz Chlubek
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

Review 2.  Therapeutic Agents for the Treatment of Temporomandibular Joint Disorders: Progress and Perspective.

Authors:  Mengjie Wu; Jingyi Cai; Yeke Yu; Sihui Hu; Yingnan Wang; Mengrui Wu
Journal:  Front Pharmacol       Date:  2021-01-29       Impact factor: 5.810

3.  Treatment of temporomandibular joint disc displacement using arthrocentesis combined with injectable platelet rich fibrin versus arthrocentesis alone.

Authors:  Nahed Ibrahim Ghoneim; Noha Ahmed Mansour; Sarah Ahmed Elmaghraby; Sally Elsayed Abdelsameaa
Journal:  J Dent Sci       Date:  2021-08-21       Impact factor: 2.080

4.  Repeated Intra-Articular Administration of Platelet-Rich Plasma (PRP) in Temporomandibular Disorders: A Clinical Case Series.

Authors:  Maciej Sikora; Marcin Sielski; Maciej Chęciński; Zuzanna Nowak; Barbara Czerwińska-Niezabitowska; Dariusz Chlubek
Journal:  J Clin Med       Date:  2022-07-22       Impact factor: 4.964

Review 5.  Interdisciplinary Approach to the Temporomandibular Joint Osteoarthritis-Review of the Literature.

Authors:  Marcin Derwich; Maria Mitus-Kenig; Elzbieta Pawlowska
Journal:  Medicina (Kaunas)       Date:  2020-05-09       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.